Literature DB >> 34546726

Multiplexed DNA-Directed Patterning of Antibodies for Applications in Cell Subpopulation Analysis.

Molly Kozminsky1, Olivia J Scheideler2, Brian Li2, Nathaniel K Liu3, Lydia L Sohn1,2,3.   

Abstract

Antibodies provide the functional biospecificity that has enabled the development of sensors, diagnostic tools, and assays in both laboratory and clinical settings. However, as multimarker screening becomes increasingly necessary due to the heterogeneity and complexity of human pathology, new methods must be developed that are capable of coordinating the precise assembly of multiple, distinct antibodies. To address this technological challenge, we engineered a bottom-up, high-throughput method in which DNA patterns, comprising unique 20-base pair oligonucleotides, are patterned onto a substrate using photolithography. These microfabricated surface patterns are programmed to hybridize with, and instruct the multiplexed assembly of, antibodies conjugated with the complementary DNA strands. We demonstrate that this simple, yet robust, approach preserves the antibody-binding functionality in two common applications: antibody-based cell capture and label-free surface marker screening. Using a simple proof-of-concept capture device, we achieved high purity separation of a breast cancer cell line, MCF-7, from a blood cell line, Jurkat, with capture purities of 77.4% and 96.6% when using antibodies specific for the respective cell types. We also show that antigen-antibody interactions slow cell trajectories in flow in the next-generation microfluidic node-pore sensing (NPS) device, enabling the differentiation of MCF-7 and Jurkat cells based on EpCAM surface-marker expression. Finally, we use a next-generation NPS device patterned with antibodies against E-cadherin, N-cadherin, and β-integrin-three markers that are associated with epithelial-mesenchymal transitions-to perform label-free surface marker screening of MCF10A, MCF-7, and Hs 578T breast epithelial cells. Our high-throughput, highly versatile technique enables rapid development of customized, antibody-based assays across a host of diverse diseases and research thrusts.

Entities:  

Keywords:  DNA-directed patterning; antibody patterning; breast cancer; cell capture; cell surface markers; node-pore sensing; photolithography

Mesh:

Substances:

Year:  2021        PMID: 34546726      PMCID: PMC8817232          DOI: 10.1021/acsami.1c15047

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  29 in total

1.  Simple, Affordable, and Modular Patterning of Cells using DNA.

Authors:  Katelyn A Cabral; David M Patterson; Olivia J Scheideler; Russell Cole; Adam R Abate; David V Schaffer; Lydia L Sohn; Zev J Gartner
Journal:  J Vis Exp       Date:  2021-02-24       Impact factor: 1.355

2.  Programmable cell adhesion encoded by DNA hybridization.

Authors:  Ravi A Chandra; Erik S Douglas; Richard A Mathies; Carolyn R Bertozzi; Matthew B Francis
Journal:  Angew Chem Int Ed Engl       Date:  2006-01-30       Impact factor: 15.336

Review 3.  Capturing complex 3D tissue physiology in vitro.

Authors:  Linda G Griffith; Melody A Swartz
Journal:  Nat Rev Mol Cell Biol       Date:  2006-03       Impact factor: 94.444

Review 4.  Selective covalent protein immobilization: strategies and applications.

Authors:  Lu Shin Wong; Farid Khan; Jason Micklefield
Journal:  Chem Rev       Date:  2009-09       Impact factor: 60.622

5.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

6.  Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.

Authors:  W Jeffrey Allard; Jeri Matera; M Craig Miller; Madeline Repollet; Mark C Connelly; Chandra Rao; Arjan G J Tibbe; Jonathan W Uhr; Leon W M M Terstappen
Journal:  Clin Cancer Res       Date:  2004-10-15       Impact factor: 12.531

7.  Isolation of rare circulating tumour cells in cancer patients by microchip technology.

Authors:  Sunitha Nagrath; Lecia V Sequist; Shyamala Maheswaran; Daphne W Bell; Daniel Irimia; Lindsey Ulkus; Matthew R Smith; Eunice L Kwak; Subba Digumarthy; Alona Muzikansky; Paula Ryan; Ulysses J Balis; Ronald G Tompkins; Daniel A Haber; Mehmet Toner
Journal:  Nature       Date:  2007-12-20       Impact factor: 49.962

8.  Interrogating cellular fate decisions with high-throughput arrays of multiplexed cellular communities.

Authors:  Sisi Chen; Andrew W Bremer; Olivia J Scheideler; Yun Suk Na; Michael E Todhunter; Sonny Hsiao; Prithvi R Bomdica; Michel M Maharbiz; Zev J Gartner; David V Schaffer
Journal:  Nat Commun       Date:  2016-01-12       Impact factor: 14.919

9.  Programmed synthesis of three-dimensional tissues.

Authors:  Michael E Todhunter; Noel Y Jee; Alex J Hughes; Maxwell C Coyle; Alec Cerchiari; Justin Farlow; James C Garbe; Mark A LaBarge; Tejal A Desai; Zev J Gartner
Journal:  Nat Methods       Date:  2015-08-31       Impact factor: 28.547

Review 10.  Development of therapeutic antibodies for the treatment of diseases.

Authors:  Ruei-Min Lu; Yu-Chyi Hwang; I-Ju Liu; Chi-Chiu Lee; Han-Zen Tsai; Hsin-Jung Li; Han-Chung Wu
Journal:  J Biomed Sci       Date:  2020-01-02       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.